A. Garfinkel, Cancer statistics and trends American Cancer Society Textbook of Clinical Oncology, [2] Mountain CF. Lung cancer staging classification, pp.2-943, 1991.

C. Moran, D. Arenberg, C. Huang, T. Giordano, D. Thomas et al., RANTES expression is a predictor of survival in stage I lung adenocarcinoma RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors CCR5 expression influences the progression of human breast cancer in a p53-dependent manner Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer, Clin Cancer Res Hum Gene Ther Blood J Exp Med Cancer Res Clin Cancer Res, vol.879319859879, pp.3803-121545, 1996.

E. Adler, C. Lemken, N. Katchen, and R. Kurt, A dual role for tumor-derived chemokine RANTES (CCL5), Immunology Letters, vol.90, issue.2-3, pp.187-94, 2003.
DOI : 10.1016/j.imlet.2003.09.013

S. Robinson, K. Scott, J. Wilson, R. Thompson, A. Proudfoot et al., A chemokine receptor antagonist inhibits experimental breast tumor growth, Cancer Res, vol.63, pp.8360-8365, 2003.

A. Yuan, P. Yang, C. Yu, W. Chen, F. Lin et al., Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non???Small-Cell Lung Cancer, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.5, pp.1957-63, 2000.
DOI : 10.1164/ajrccm.162.5.2002108

D. Arenberg, S. Kunkel, P. Polverini, M. Glass, M. Burdick et al., Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice., Journal of Clinical Investigation, vol.97, issue.12, pp.2792-802, 1996.
DOI : 10.1172/JCI118734

B. Moore, D. Arenberg, K. Stoy, T. Morgan, C. Addison et al., Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer Cells, The American Journal of Pathology, vol.154, issue.5, pp.1503-1515, 1999.
DOI : 10.1016/S0002-9440(10)65404-1

K. Inoue, J. Slaton, S. Kim, P. Perrotte, B. Eve et al., INTERLEUKIN-8 (IL-8) EXPRESSION REGULATES TUMORIGENICITY AND METASTASIS IN HUMAN BLADDER CANCER, The Journal of Urology, vol.60, pp.2290-2299, 2000.
DOI : 10.1097/00005392-199904010-00483

R. Salcedo, M. Martins-green, B. Gertz, J. Oppenheim, and W. Murphy, Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts, Clin Cancer Res, vol.8, pp.2655-65, 2002.

S. Huang, L. Mills, B. Mian, C. Tellez, M. Mccarty et al., Fully Humanized Neutralizing Antibodies to Interleukin-8 (ABX-IL8) Inhibit Angiogenesis, Tumor Growth, and Metastasis of Human Melanoma, The American Journal of Pathology, vol.161, issue.1, pp.125-159, 2002.
DOI : 10.1016/S0002-9440(10)64164-8

L. Lee, R. Hellendall, Y. Wang, J. Haskill, N. Mukaida et al., IL-8 Reduced Tumorigenicity of Human Ovarian Cancer In Vivo Due to Neutrophil Infiltration, The Journal of Immunology, vol.164, issue.5, pp.2769-75, 2000.
DOI : 10.4049/jimmunol.164.5.2769

F. Balkwill, Cancer and the chemokine network, Nature Reviews Cancer, vol.62, issue.7, pp.540-50, 2004.
DOI : 10.1038/35102167

S. Mocellin, C. Rossi, P. Pilati, and D. Nitti, Tumor necrosis factor, cancer and anticancer therapy, Cytokine & Growth Factor Reviews, vol.16, issue.1, pp.35-53, 2005.
DOI : 10.1016/j.cytogfr.2004.11.001

H. Mackay and C. Twelves, Protein kinase C: a target for anticancer drugs?, Endocrine Related Cancer, vol.10, issue.3, pp.389-96, 2003.
DOI : 10.1677/erc.0.0100389

J. Koivunen, V. Aaltonen, and J. Peltonen, Protein kinase C (PKC) family in cancer progression, Cancer Letters, vol.235, issue.1, pp.1-10, 2006.
DOI : 10.1016/j.canlet.2005.03.033

H. Moriuchi, M. Moriuchi, and A. Fauci, Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection, J Immunol, vol.158, pp.3483-91, 1997.

A. Freund, V. Jolivel, S. Durand, N. Kersual, D. Chalbos et al., Mechanisms underlying differential expression of interleukin-8 in breast cancer cells, Oncogene, vol.23, issue.36, pp.6105-6119, 2004.
DOI : 10.1038/sj.onc.1207815
URL : https://hal.archives-ouvertes.fr/inserm-00143639

S. Vincent, M. L. Fort, and P. , S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues, Nucleic Acids Research, vol.21, issue.6, p.1498, 1993.
DOI : 10.1093/nar/21.6.1498

M. Mathieu, C. Gougat, D. Jaffuel, M. Danielsen, P. Godard et al., The glucocorticoid receptor gene as a candidate for gene therapy in asthma, Gene Therapy, vol.6, issue.2, pp.245-52, 1999.
DOI : 10.1038/sj.gt.3300814

B. Stein, H. Rahmsdorf, A. Steffen, M. Litfin, and P. Herrlich, UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein., Molecular and Cellular Biology, vol.9, issue.11, pp.5169-81, 1989.
DOI : 10.1128/MCB.9.11.5169

G. Pearson, F. Robinson, B. Gibson, T. Xu, B. Karandikar et al., Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions, Endocrine Reviews, vol.22, issue.2, pp.153-83, 2001.
DOI : 10.1210/er.22.2.153

N. Sizemore, N. Lerner, N. Dombrowski, H. Sakurai, and G. Stark, Distinct Roles of the I??B Kinase ?? and ?? Subunits in Liberating Nuclear Factor ??B (NF-??B) from I??B and in Phosphorylating the p65 Subunit of NF-??B, Journal of Biological Chemistry, vol.277, issue.6, pp.3863-3872, 2002.
DOI : 10.1074/jbc.M110572200

S. Faisst and S. Meyer, Compilation of vertebrate-encoded transcription factors, Nucleic Acids Research, vol.20, issue.1, pp.3-26, 1992.
DOI : 10.1093/nar/20.1.3

L. Vermeulen, D. Wilde, G. Notebaert, S. , V. Berghe et al., Regulation of the transcriptional activity of the nuclear factor-??B p65 subunit, Biochemical Pharmacology, vol.64, issue.5-6, pp.963-70, 2002.
DOI : 10.1016/S0006-2952(02)01161-9

E. Kohn, C. Yoo, and A. Eastman, The protein kinase C inhibitor Go6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints, Cancer Res, vol.63, pp.31-36, 2003.

J. Koivunen, V. Aaltonen, S. Koskela, P. Lehenkari, M. Laato et al., Protein Kinase C ??/?? Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells, Cancer Research, vol.64, issue.16, pp.5693-701, 2004.
DOI : 10.1158/0008-5472.CAN-03-3511

L. Paz-ares, J. Douillard, P. Koralewski, C. Manegold, E. Smit et al., Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.24, issue.9, pp.1428-1462, 2006.
DOI : 10.1200/JCO.2005.04.3299

G. Schwartz, J. Jiang, D. Kelsen, and A. Albino, Protein Kinase C: A Novel Target for Inhibiting Gastric Cancer Cell Invasion, JNCI Journal of the National Cancer Institute, vol.85, issue.5, pp.402-409, 1993.
DOI : 10.1093/jnci/85.5.402

J. Zhang, P. Anastasiadis, Y. Liu, E. Thompson, and A. Fields, Protein Kinase C (PKC) ??II Induces Cell Invasion through a Ras/Mek-, PKC??/Rac 1-dependent Signaling Pathway, Journal of Biological Chemistry, vol.279, issue.21, pp.22118-22141, 2004.
DOI : 10.1074/jbc.M400774200

N. Murray, L. Davidson, R. Chapkin, C. Gustafson, W. Schattenberg et al., Induces Colonic Hyperproliferation and Increased Sensitivity to Colon Carcinogenesis, The Journal of Cell Biology, vol.24, issue.4, pp.699-711, 1999.
DOI : 10.1083/jcb.141.3.765